pharmaphorum

FEBRUARY 18, 2021

In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. 10 Since FDA approval in 1998 the ‘Little Blue Pill’ had some of the fastest prescription uptakes and sales growth of any medication, bringing in $400 million in revenue in its first quarter after launch and going on to produce annual sales of about $1.8

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

FDA Law Blog: Biosimilars

DECEMBER 4, 2023

A red flag does not prohibit a pharmacist from filling a prescription but is a potential concern with the prescription that the pharmacist must address and resolve. If the pharmacist can resolve it, they must make a record of the resolution. Complaint ¶ 55.

Controlled Substances 139

Controlled Substances Documentation Dosage Prescription Filling 139

Quality Matters

APRIL 26, 2023

In 2017, the Asia-Pacific Economic Cooperation (APEC) forum designated USP as an APEC Center of Excellence (CoE) through the sponsorship of the U.S. Essential elements of a strong, global medicines supply chain The U.S. Pharmacopeia (USP) has long been recognized as an international leader in medicines quality and supply chain integrity.

Prescription Filling 52

Prescription Filling Generic Medicine Packaging Labelling 52

pharmaphorum

MAY 10, 2022

Hutnik shared a story from her experience where tracking community adoption of a therapy helped them to target more receptive communities, leading to prescription fills almost eight times higher. And I think this is well doable now.”. Advice for communicators.

Communication 98

Communication Prescription Filling Pharmaceutical Companies Pharmaceutical Companies 98

Putting Patients First Blog

MAY 29, 2024

Prior authorization and association with delayed or discontinued prescription fills. Retrieved from https ://www.acc.org/latest-in- cardiology/articles/2017/02/21/12/42/barriers-to-new-medications-for-cardiovascular-disease-insights- from-cardiosurve? and Keating, N. Journal of Clinical Oncology, 42(8). link] 9 Chino, F.,

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Prescription Filling Hospitals 52

Putting Patients First Blog

SEPTEMBER 3, 2024

Prior authorization and association with delayed or discontinued prescription fills. Retrieved from [link] www.acc.org/latest-in- cardiology/articles/2017/02/21/12/42/barriers-to-new-medications-for-cardiovascular-disease-insights- from-cardiosurve? and Keating, N. Journal of Clinical Oncology, 42(8). link] 4 Chino, F.,

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Putting Patients First Blog

JULY 2, 2024

Prior authorization and association with delayed or discontinued prescription fills. Retrieved from https ://www.acc.org/latest-in- cardiology/articles/2017/02/21/12/42/barriers-to-new-medications-for-cardiovascular-disease-insights- from-cardiosurve? and Keating, N. Journal of Clinical Oncology, 42(8). link] xii Chino, F.,

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing HIPAA Labelling 52